Share Name Share Symbol Market Type Share ISIN Share Description
Tyratech (DI/S) LSE:TYR London Ordinary Share COM SHS USD0.001 (DI / REGS)
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 2.95 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
2.70 3.20 0.00 0.00 0.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 0.88 -2.88 2.22 1.3 6
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 2.95 GBX

Tyratech (TYR) Latest News

Real-Time news about Tyratech (DI/S) (London Stock Exchange): 0 recent articles
More Tyratech News
Tyratech Takeover Rumours

Tyratech (TYR) Discussions and Chat

Tyratech Forums and Chat

Date Time Title Posts
11/1/201815:20TyraTech - Putting Nature to Work1,753
12/4/201615:01Alan Reade, Chairman of TyraTech offers a discussion on TyraTech1
18/7/201409:15Pests For You?458

Add a New Thread

Tyratech (TYR) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Tyratech trades in real-time

Tyratech (TYR) Top Chat Posts

thegrumpster: This has to be one of the most disappointing shares on AIM. They just do not seem to be able to make a go of anything. Used to be in this one years and years ago (2009? Pre TYRU) Actually made a bit of money when everything on AIM was going up. Got out because of some "dodgy" fund was involved (supposedly known for lending money, then pulling the plug)...they've gone. And there were too few trades....first person to sell crashed the share price. The University also seemed to be sliding out quietly....didn't seem to take part in additional fundraising, and they're not short of a bob or two. Lack of faith in their own technology, or the people running the company? The opportunities for their products are still out there. This for example, still relevant: Http:// ""According to Edinburgh University's Centre for Tropical Medicine, midges respond to the combination of chemicals - including lactic acid - present in the sweat of certain people, which they detect via their highly sensitive antennae. Research is focusing on the development of a repellent that can block receptor sites on midge antennae, but until such a product becomes available, those of us who are vulnerable must find other ways to manage the midges." "....It is estimated that midges cost the Scottish tourist industry up to £268 million a year in lost revenue, because many avoid visits during midge season. A forestry study carried out in the mid-1980s also suggested that 20 per cent of working days were lost because clouds of biting midges make timber felling and tree planting nigh impossible."" £268 million ten years ago. What are they losing now with the low pound, and the UK being a cheap destination for holidays? Midges? Http:// 2007 Tyratech 480p +20 Questor says Buy (Those were the days ....480 pee) Http:// "The arrival in the UK of the bluetongue virus this week, blown into the country by midges, served as a useful reminder than insect bites are not just a pain in the proverbial. They can devastate farmers' livelihoods and have brought animal movements across East Anglia to a complete halt. So it was particularly timely for Tyratech to publish its maiden results yesterday. The start-up (it listed on Aim this summer) is among a new breed of companies creating technology that should help create potent pesticides out of natural materials. It has located a number of receptors in parasites and insects that react to natural products. While this has been done before, the results have not always been totally effective. Tyratech claims to have taken the development a stage further, so that its plant-based products are now more powerful than chemical rivals. The potential benefits are enormous. Tyratech's natural products do less damage to the environment – increasingly important –as well as offering an alternative against insects that have developed a resistance to traditional products. What is more, as the receptors in insects are not found in mammals, the pesticides are literally fit to drink, and Tyratech is hoping to develop products that can combat intestinal parasites. As an investment case, the potential is clear but the risks are great. Tyratech's products are novel and it does not have a proven track record. The shares trade on a multiple of 30 times forecast earnings for 2009 (the first year it is expected to make a profit) falling to five times for 2011. It is not one for short-term investors or the risk-averse, but for others it's worth a punt." Seem to remember it was only about 30,000 shares sold, that brought it finally down to about 12p, in 2008, when things started looking ropey. Http:// They've even got a product. Hopeless innit.
mudbath: I think it maybe has to do with the Spreadex holding of 8,650,000 TYR shares.If they have a client with a large position at around 1.75 pence,it might make sense to let the whole(or remaining)amount overhang the market whilst any contract moves towards expiry. If this is the case then we could see a sharp reversal in the TYR share price once the contract expires or even if it is rolled over. imo.
casablanca4: Thanks for that dice. Like other CEO's he can talk to the cows come home, as the share price languishes, Thought this was a great buy a few years ago but what do I know. Strange the way the price hasn't gone up. Unseen skeletons? Good luck.
haroldthegreat: when you are there next ask the pharmacist how often they sell them and what feedback they get.ask which are their best selling lice products, they will have nothing to hide and will give you an honest answer. you can then post it here for others to read. if you ask a professional the reply you get will give you more accurate information than on a board. the share price should tell you what the market thinks. for the record i have not had one person ask me for it!. i have sold one pack because i got fed up with looking at them. i asked the patient to tell me how they found it and they never reported back.
michaelsadvfn: Interesting bit from the placing RNS.. Company took the opportunity to withdraw the exclusivity under this agreement and is now pursuing alternative commercialisation strategies, one of them being marketing the products under its own PureScience(TM) brand in 2016. Thruppence a share, disastrous share price performance & I can't see it getting any better anytime soon.
nobbygnome: Seems like the announcement makes sense. As I said a while ago, it is all about Vamousse in the short term. In addition, the cash will reduce the chance of needing another fund raising, which is probably the most important thing in terms of the share price! It will be interesting to see the market reaction (if any). GLA Nobby
michaelsadvfn: Results in June superg1. Don't expect any surprises, Tyratech isn't about 2014, it's about H2 '15 and more likely 2016. You either believe in the business or you don't. I do. I can't think of any other company that has gotten it's foot in so many doors in such a short space of time both across the USA and in the UK. These retailers all like what they have seen and believe it will sell otherwise they wouldn't stock the stuff in the first place. As ever, patience is key. Unfortunately there's not a lot of that around the AIM market hence the depressed share price.
michaelsadvfn: Nice update. With the share price down by a third on this time last year there is plenty of room for a rerating here. I can't quite understand why this stock is so out of favour.
michaelsadvfn: Well after watching TYRU rise 20% today and TYR do nothing I picked up 100k TYR at silly prices. The current share price is below the price before half the world started selling VaMousse so even more of a bargain than it was a year ago. Ta very much Mr. Market.
jxman: Cambridge post Friday 28th feb TyraTech starting to make its markScan the list of UK quoted stocks and there are numerous examples of the classic falling knife. However, there can be few cases to rival the share price demise as that of chemical company TyraTech Inc.Although based in the US, TyraTech is listed over here and, perhaps surprisingly, boasts the presence of Standard life and Legal & General among others as major shareholders.Currently at 32p, the company has somehow clawed itself back from the brink, having seen its share price collapse from close to £5 three years back.While much of the early excitement and momentum behind those heady days evaporated, there are now, nevertheless, signs of a company that is beginning to gain recognition across its field.Such pointers could be worth exploring further and perhaps suggest that TyraTech could now be an attractive, albeit speculative, punt.Although firmly cast in the chemical sector by being a developer and producer of pesticides, any alignment to the conventional producers can be quickly dismissed.This is because TyraTech's offerings are based on and derived from natural ingredients before being harnessed to target only invertebrate pests that attack crops as well as people and pets.This is good news from a number of angles, including effectiveness, but importantly safety, as the products are not harmful to humans or animals.Having secured its own patents on the technology, the company, which can be seen as an eco-tech pesticide producer, has established products derived from natural plant oils and which are subsequently formulated to attack and effectively destroy their targets.Although it has taken TyraTech longer than originally anticipated to make its mark, some notable deals suggest it could grab a piece of what is potentially a massive global market.The estimated worth of the combined pesticide market for domestic and agricultural customers is said to be worth a staggering $33bn.And here the company has already gained acceptance by being aligned to the world's largest pesticide player, Terminix. A deal is already in place whereby Terminix is marketing TyraTech's technology as SafeShield Natural, supplying customers across the US, Canada and Mexico. Set to run to at least 2017, it is complemented by another collaboration with the giant Kraft food company, where the latter is using TyraTech's technology within its exciting functional foods programme.These alliances, along with others such as Arysta Lifesciences and Natural Forces Inc., should help build up earnings momentum in the coming years.House broker Brewin Dolphin is forecasting profits for next year and has pencilled in £1.34m pre-tax, along with EPS of 2.5p.If TyraTech can achieve that and continue to attract further blue chip client interest, then the shares look worth a punt at current levels. Read more:
Tyratech share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200808 00:49:48